3,4-Dibromo-Mal-PEG4-Val-Cit-PAB-MMAE serves as a peptide linker that can be used in the creation of antibody drug conjugates (ADCs). The dibromomaleimide group allows for two points of substitution due to the two bromine atoms. Dibromo-Maleimide is sensitive to high temperature and light. The cathepsin-cleavable Val-Cit-PAB dipeptide is ligated to an MMAE payload. The PEG4 chain improves the water-solubility of the compound. Reagent grade, for research purpose. Please contact us for GMP-grade inquiries.
Usually ships within 24 hours.